The role of α5-nicotinic acetylcholine receptor/NLRP3 signaling pathway in lung adenocarcinoma cell proliferation and migration
Authors:
- 4 February 2022
- journal article
- research article
- Published by Elsevier in Toxicology
- Vol. 469, 153120
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- TheCHRNA5/CHRNA3/CHRNB4Nicotinic Receptor Regulome: Genomic Architecture, Regulatory Variants, and Clinical AssociationsHuman Mutation, 2016
- Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes — A Meta-AnalysisEBioMedicine, 2016
- Smokers are less likely than non-smokers to seek help for a lung cancer ‘alarm’ symptomThorax, 2016
- The Oncogenic Functions of Nicotinic Acetylcholine ReceptorsJournal of Oncology, 2016
- Activation of NLRP3 inflammasome enhances the proliferation and migration of A549 lung cancer cellsOncology Reports, 2016
- Recent progress in revealing the biological and medical significance of the non-neuronal cholinergic systemInternational Immunopharmacology, 2015
- α5-nAChR modulates nicotine-induced cell migration and invasion in A549 lung cancer cellsExperimental and Toxicologic Pathology, 2015
- Chromatin Immunoprecipitation Assays: Analyzing Transcription Factor Binding and Histone Modifications In Vivo2015
- Contribution of Variants in CHRNA5/A3/B4 Gene Cluster on Chromosome 15 to Tobacco Smoking: From Genetic Association to MechanismMolecular Neurobiology, 2014
- Alpha5 nicotinic acetylcholine receptor mediates nicotine-induced HIF-1α and VEGF expression in non-small cell lung cancerToxicology and Applied Pharmacology, 2014